PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LeMaitre Vascular, Inc. (LMAT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US5255582018

CUSIP

525558201

Sector

Healthcare

IPO Date

Oct 19, 2006

Highlights

Market Cap

$1.95B

EPS (TTM)

$1.97

PE Ratio

43.80

PEG Ratio

2.27

Total Revenue (TTM)

$166.39M

Gross Profit (TTM)

$112.76M

EBITDA (TTM)

$52.49M

Year Range

$61.90 - $109.31

Target Price

$105.63

Short %

7.49%

Short Ratio

4.38

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
LMAT vs. ZBH LMAT vs. FXAIX LMAT vs. SPY LMAT vs. VOO LMAT vs. DVA LMAT vs. ^GSPC LMAT vs. UTHR LMAT vs. COO LMAT vs. TGS
Popular comparisons:
LMAT vs. ZBH LMAT vs. FXAIX LMAT vs. SPY LMAT vs. VOO LMAT vs. DVA LMAT vs. ^GSPC LMAT vs. UTHR LMAT vs. COO LMAT vs. TGS

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in LeMaitre Vascular, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


500.00%1,000.00%1,500.00%2,000.00%NovemberDecember2025FebruaryMarchApril
1,549.37%
286.46%
LMAT (LeMaitre Vascular, Inc.)
Benchmark (^GSPC)

Returns By Period

LeMaitre Vascular, Inc. had a return of -6.13% year-to-date (YTD) and 38.89% in the last 12 months. Over the past 10 years, LeMaitre Vascular, Inc. had an annualized return of 27.36%, outperforming the S&P 500 benchmark which had an annualized return of 9.70%.


LMAT

YTD

-6.13%

1M

1.72%

6M

-3.62%

1Y

38.89%

5Y*

25.23%

10Y*

27.36%

^GSPC (Benchmark)

YTD

-10.18%

1M

-6.92%

6M

-9.92%

1Y

5.42%

5Y*

12.98%

10Y*

9.70%

*Annualized

Monthly Returns

The table below presents the monthly returns of LMAT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.20%-5.24%-8.43%2.84%-6.13%
20242.26%20.61%-4.97%-2.35%21.98%4.31%5.60%4.12%2.88%-4.84%21.23%-13.88%63.63%
20232.52%6.21%3.01%4.92%16.62%7.07%-6.02%-8.35%-5.76%-10.83%8.77%7.70%24.60%
2022-15.77%12.20%-1.85%-7.02%6.11%-0.37%10.54%-1.69%2.63%-14.36%8.24%-1.77%-7.40%
202118.67%6.93%-4.85%7.56%-2.18%19.16%-10.75%4.17%-6.23%-2.03%-9.85%7.35%25.10%
20200.10%-20.80%-12.27%14.33%-5.26%-1.82%11.10%10.40%0.77%-0.15%21.57%2.82%14.09%
20190.85%25.50%3.89%-6.84%-10.35%8.41%18.26%-4.06%7.96%1.23%3.06%1.07%53.77%
20189.30%-0.11%4.43%-13.19%8.58%-1.76%7.53%4.39%3.28%-31.08%4.72%-15.24%-25.13%
2017-10.38%-2.51%11.50%20.79%2.91%2.16%15.53%1.08%2.80%-14.46%3.04%-3.31%26.58%
2016-15.36%0.89%5.69%6.83%-15.49%2.15%20.53%7.14%7.94%5.54%8.47%11.78%48.46%
20153.92%-4.15%10.53%8.11%12.36%18.93%18.08%-6.90%-7.79%9.27%16.17%11.80%128.82%
2014-0.50%2.76%-1.04%1.74%-7.88%9.83%-1.94%-9.57%-5.75%6.40%0.91%4.08%-2.73%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 83, LMAT is among the top 17% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LMAT is 8383
Overall Rank
The Sharpe Ratio Rank of LMAT is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of LMAT is 8181
Sortino Ratio Rank
The Omega Ratio Rank of LMAT is 7979
Omega Ratio Rank
The Calmar Ratio Rank of LMAT is 8989
Calmar Ratio Rank
The Martin Ratio Rank of LMAT is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for LMAT, currently valued at 1.05, compared to the broader market-2.00-1.000.001.002.003.00
LMAT: 1.05
^GSPC: 0.24
The chart of Sortino ratio for LMAT, currently valued at 1.60, compared to the broader market-6.00-4.00-2.000.002.004.00
LMAT: 1.60
^GSPC: 0.47
The chart of Omega ratio for LMAT, currently valued at 1.21, compared to the broader market0.501.001.502.00
LMAT: 1.21
^GSPC: 1.07
The chart of Calmar ratio for LMAT, currently valued at 1.29, compared to the broader market0.001.002.003.004.00
LMAT: 1.29
^GSPC: 0.24
The chart of Martin ratio for LMAT, currently valued at 3.54, compared to the broader market-5.000.005.0010.0015.0020.00
LMAT: 3.54
^GSPC: 1.08

The current LeMaitre Vascular, Inc. Sharpe ratio is 1.05. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of LeMaitre Vascular, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.05
0.24
LMAT (LeMaitre Vascular, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

LeMaitre Vascular, Inc. provided a 0.79% dividend yield over the last twelve months, with an annual payout of $0.68 per share. The company has been increasing its dividends for 13 consecutive years.


0.60%0.80%1.00%1.20%1.40%1.60%1.80%$0.00$0.10$0.20$0.30$0.40$0.50$0.6020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.68$0.64$0.56$0.50$0.44$0.38$0.34$0.28$0.22$0.18$0.16$0.14

Dividend yield

0.79%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%1.83%

Monthly Dividends

The table displays the monthly dividend distributions for LeMaitre Vascular, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.20$0.00$0.20
2024$0.00$0.00$0.16$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64
2023$0.00$0.00$0.14$0.00$0.14$0.00$0.00$0.14$0.00$0.00$0.14$0.00$0.56
2022$0.00$0.00$0.13$0.00$0.13$0.00$0.00$0.13$0.00$0.00$0.13$0.00$0.50
2021$0.00$0.00$0.11$0.00$0.11$0.00$0.00$0.11$0.00$0.00$0.11$0.00$0.44
2020$0.00$0.00$0.10$0.00$0.10$0.00$0.00$0.10$0.00$0.00$0.10$0.00$0.38
2019$0.00$0.00$0.09$0.00$0.09$0.00$0.00$0.09$0.00$0.00$0.09$0.00$0.34
2018$0.00$0.00$0.07$0.00$0.07$0.00$0.00$0.07$0.00$0.00$0.07$0.00$0.28
2017$0.00$0.00$0.06$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.22
2016$0.00$0.00$0.05$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.18
2015$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16
2014$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.14

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
LMAT: 0.8%
LeMaitre Vascular, Inc. has a dividend yield of 0.79%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%
LMAT: 35.1%
LeMaitre Vascular, Inc. has a payout ratio of 35.05%, which is quite average when compared to the overall market. This suggests that LeMaitre Vascular, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-19.89%
-14.02%
LMAT (LeMaitre Vascular, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the LeMaitre Vascular, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LeMaitre Vascular, Inc. was 75.69%, occurring on Dec 23, 2008. Recovery took 1200 trading sessions.

The current LeMaitre Vascular, Inc. drawdown is 19.89%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-75.69%Nov 26, 2007243Dec 23, 20081200Oct 24, 20131443
-47.65%Apr 20, 2018484Mar 23, 2020172Nov 24, 2020656
-37.93%Jun 28, 2021219May 9, 2022247May 3, 2023466
-33.32%Jun 26, 202387Oct 26, 202384Feb 28, 2024171
-29.66%Dec 30, 201536Feb 22, 2016112Aug 1, 2016148

Volatility

Volatility Chart

The current LeMaitre Vascular, Inc. volatility is 12.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
12.24%
13.60%
LMAT (LeMaitre Vascular, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of LeMaitre Vascular, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how LeMaitre Vascular, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
LMAT: 43.8
The chart displays the Price-to-Earnings (P/E) ratio for LMAT, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, LMAT has a P/E ratio of 43.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
LMAT: 2.3
The chart shows the Price/Earnings to Growth (PEG) ratio for LMAT compared to other companies in the Medical Instruments & Supplies industry. LMAT currently has a PEG ratio of 2.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
2.04.06.08.010.0
LMAT: 8.9
This chart shows the Price-to-Sales (P/S) ratio for LMAT relative to other companies in the Medical Instruments & Supplies industry. Currently, LMAT has a P/S ratio of 8.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
2.04.06.08.010.0
LMAT: 5.8
The chart illustrates the Price-to-Book (P/B) ratio for LMAT in comparison with other companies in the Medical Instruments & Supplies industry. Currently, LMAT has a P/B value of 5.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for LeMaitre Vascular, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab